Myriad Genetics Logo

Myriad Genetics

🇺🇸
MYGN
US62855J1043

Myriad Genetics is a leader in precision medicine, developing and marketing advanced genetic tests. These tests aid in the diagnosis, prognosis, and therapeutic decision-making for cancer and hereditary diseases. The company enhances patient care through innovative diagnostics, empowering healthcare providers with critical genetic insights for better outcomes.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
After-Hours
In 25 days

Stock Price

All Dates

Company Information

Name
Myriad Genetics
Ticker Symbol
MYGN
ISIN
US62855J1043
Country
🇺🇸
USA